Serial Number | 97424195 |
Word Mark | SONATA THERAPEUTICS |
Filing Date | Monday, May 23, 2022 |
Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
Status Date | Friday, March 29, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the stylized word "SONATA" positioned above the stylized word "THERAPEUTICS". The letter "O" in "SONATA" forms a sun design with rays that are represented by a multitude of dot designs. The colors black and white represent background, outlining, shading, and transparent areas and are not claimed as features of the mark. |
Goods and Services | Pharmaceutical agents and products, namely, pharmaceutical agents for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical compositions in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation, namely, pharmaceutical preparations for the treatment of cancer |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Disclaimer with Predetermined Text | "THERAPEUTICS" |
Goods and Services | Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; technical scientific research consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development of pharmaceutical data in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 1, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, April 6, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Sonata Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Watertown, MA 02472 |
Event Date | Event Description |
Tuesday, April 2, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, April 2, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, April 2, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Friday, March 29, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Thursday, September 28, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, September 28, 2023 | LETTER OF SUSPENSION E-MAILED |
Thursday, September 28, 2023 | SUSPENSION LETTER WRITTEN |
Wednesday, August 23, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, August 23, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, August 23, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, May 23, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, May 23, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, May 23, 2023 | NON-FINAL ACTION WRITTEN |
Tuesday, April 25, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, April 25, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, April 25, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, April 6, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, April 5, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, April 5, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, April 3, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, April 3, 2023 | NON-FINAL ACTION E-MAILED |
Monday, April 3, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, March 9, 2023 | ASSIGNED TO EXAMINER |
Thursday, June 2, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Wednesday, June 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |